Patterns and Predictors of Successful Treatment Discontinuation in Retinal Vein Occlusions with Macular Edema in the Real World

Written by: Nika Bagheri, MD March 2021 Therlinder Lo, Lent-Schochet D, Luu KY, Kuriyan AE, Weiss MY, Rachitskaya AV, Singh RP, Wai KM, Campbell JP, Gupta K, Nudleman E, Chen KC, Yiu G. Patterns and Predictors of Successful Treatment Discontinuation in Retinal Vein Occlusions with Macular Edema in the Real World. OSLI Retina 2021; 52(2):84-92. […]

Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration

Written by: Mehnaz Khan, MD March 2021 Hwang CK, Agrón E, Domalpally A, Cukras CA, Wong WT, Chew EY, Keenan TDL; AREDS2 Research Group. Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-Related Macular Degeneration: AREDS2 Report 24. Ophthalmol Retina. 2021 Feb;5(2):108-117. doi: 10.1016/j.oret.2020.10.008. Epub 2020 Oct 16. PMID: 33075546; PMCID: PMC7870515. One […]

Cost Analysis of Routine Vitrectomy Surgery

Written by: Avni P. Finn, MD March 2021 Berkowitz S.T., Sternberg P., Jr & Patel S., Cost Analysis of Routine Vitrectomy Surgery, Ophthalmology Retina, Published February 11, 2021, DOI: https://doi.org/10.1016/j.oret.2021.02.003. Due to rising healthcare costs, value-based healthcare reform has been at the forefront of healthcare delivery and policy. In this model, healthcare is reimbursed according […]

Eplerenone for Chronic Central Serous Chorioretinopathy – (VICI): a Randomised, Double-blind, Placebo-Controlled Trial

Written by: Christian J. Sanfilippo, MD February 2021 Lotery, A., Sivaprasad, S., O’Connell, A., Harris, R. A., Culliford, L., Ellis, L., … Chakravarthy, U. (2020). Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. The Lancet, 395(10220), 294–303. doi:10.1016/s0140-6736(19)32981-2  Central serous chorioretinopathy […]

Outcomes of Combined Phacoemulsification and Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparative Study

Written by: Jaya B. Kumar, MD February 2021 Tan A, Bertrand-Boiché M, Angioi-Duprez K, Berrod J, Conart J. Outcomes of Combined Phacoemulsification and Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparative Study. Retina 2021; 41:68-74. For the majority of retina surgeons, pars plana vitrectomy (PPV) has become the preferred technique to repair primary rhegmatogenous […]

Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study

Written by: Wenlan (Wendy) Zhang, MD January 2021 Spooner KL, Fraser-Bell S, Cozzi M, Staurenghi G, Invernizzi A, Monteduro D, Munk MR, Hong T, Chang AA. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of […]

Factors Associated With the Use of 360-Degree Laser Retinopexy During Primary Vitrectomy With or Without Scleral Buckle for Rhegmatogenous Retinal Detachment and Impact on Surgical Outcomes

Written by: Andrew Tye, MD January 2021 Wang JC, Ryan EH, Ryan C, Kakulavarapu S, Mardis PJ, Rodriguez M, Stefater JA, Forbes NJ, Gupta O, Capone A Jr, Emerson GG, Joseph DP, Eliott D, Yonekawa Y; Primary Retinal Detachment Outcomes (PRO) Study Group. FACTORS ASSOCIATED WITH THE USE OF 360-DEGREE LASER RETINOPEXY DURING PRIMARY VITRECTOMY […]